01/04/2024

To,

PRISM MEDICO & PHARMACY LIMITED - INE730E01016

Dear Sir/Madam.

Sub : Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018

As per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby confirm that security received from the depository participants for dematerialisation during the month ended March, 2024, were confirmed (accepted / rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued securities are listed.

We hereby also confirm that the security certificates received for dematerialisation have been confirmed/rejected and the security certificates received were mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines. We request you to kindly take note of the above in your records.

Thanking you,

Yours faithfully,

For Purva Sharegistry (India) Pvt. Ltd.

Ms. Deepali Dhuri

Compliance Officer.

PRISM MEDICO & PHARMACY LIMITED - INE730E01016 - Details of Share certificates dematerialised from 01/03/2024 to 31/03/2024

FOLIO

NAME OF

CERTIFICATE

DIST. NO.

DIST. NO.(TO)

SHARES

DEMATERIALIS

SHAREHOLDE

NO.

(FROM)

ED ON

R

NIL

NIL

NIL

NIL

NIL

NIL

NIL

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Prism Medico and Pharmacy Ltd. published this content on 13 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 April 2024 11:46:01 UTC.